Jubilant HollisterStier’s Contract Manufacturing & Services division has won contracts with four innovator life science companies for the commercial manufacture of sterile parenteral products for sale in the U.S. and Europe. The company will manufacture the products, which range from liquid to lyophilization presentations, at its Spokane, WA facility. The contracts are valued at more than $90 million and will be executed during a period of five years.

“We have successfully helped provide safe and effective products to innovator pharmaceutical and biotechnology companies over the years and are committed to do so for these products as well. We are pleased to offer our support in the development and manufacture of highly complex products through the application of leading scientific solutions and utmost dedication to quality and customer service. This expansion of our globally leading parenteral manufacturing capabilities is a further outcome of our strategy to extend our offering across products and geographies.” said Marcelo Morales, chief executive officer, Jubilant HollisterStier.